Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled multicenter double-blind study of extended-release methylphenidate in adults with cancer-related fatigue
2006-000585-36Phase 2Completed
- Sponsor
- Medice
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer-related fatigue (CRF) comparing Methylphenidate extended-release with Placebo (2 arms). Primary endpoint: Individual fatigue score per MFI fatigue scale (0–100). Started Apr 2006; status: completed.
02
Drugs
methylphenidate
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on 2006-000585-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000585-36.